Evidence map›Paper›PMID 21079690›Full record

ArticlePLoS pathogens2010

Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium.

Louise Slater, Nathan W Bartlett, Jennifer J Haas, Jie Zhu, Simon D Message, Ross P Walton, Annemarie Sykes, Samer Dahdaleh, Deborah L Clarke, Maria G Belvisi and 5 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 185 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
185citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

185 citing papers in PubMed, 1 synthesis or guideline pooled it, 311 citations in OpenAlex.

  1. Pooled it
  2. Lower viral loads in subjects with rhinovirus-challenged allergy despite reduced innate immunity.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Trial
  3. Trial
  4. Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6.American journal of respiratory cell and molecular biology · 2021
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. The rhinovirus puzzle: Linking virus and host factors to childhood asthma.The Journal of allergy and clinical immunology · 2026
    Review
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

125 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Louise SlaterDepartment of Respiratory Medicine, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Nathan W Bartlett
Jennifer J Haas
Jie Zhu
Simon D Message
Ross P Walton
Annemarie Sykes
Samer Dahdaleh
Deborah L Clarke
Maria G Belvisi
Onn M Kon
Takashi Fujita
Peter K Jeffery
Sebastian L Johnston
Michael R Edwards
Imperial College London · GBAsthma UK · GBImperial College Healthcare NHS Trust · GBKyoto University · JP

Funding

Biotechnology and Biological Sciences Research Council BB/E52708X/1Medical Research Council G0601236Medical Research Council G0700552Wellcome Trust
6 · The paper itself

Abstract

The relative roles of the endosomal TLR3/7/8 versus the intracellular RNA helicases RIG-I and MDA5 in viral infection is much debated. We investigated the roles of each pattern recognition receptor in rhinovirus infection using primary bronchial epithelial cells. TLR3 was constitutively expressed; however, RIG-I and MDA5 were inducible by 8-12 h following rhinovirus infection. Bronchial epithelial tissue from normal volunteers challenged with rhinovirus in vivo exhibited low levels of RIG-I and MDA5 that were increased at day 4 post infection. Inhibition of TLR3, RIG-I and MDA5 by siRNA reduced innate cytokine mRNA, and increased rhinovirus replication. Inhibition of TLR3 and TRIF using siRNA reduced rhinovirus induced RNA helicases. Furthermore, IFNAR1 deficient mice exhibited RIG-I and MDA5 induction early during RV1B infection in an interferon independent manner. Hence anti-viral defense within bronchial epithelium requires co-ordinated recognition of rhinovirus infection, initially via TLR3/TRIF and later via inducible RNA helicases.

Indexed as

AnimalsBlotting, WesternBronchiCells, CulturedDEAD Box Protein 58DEAD-box RNA HelicasesEpitheliumFemaleFluorescent Antibody TechniqueHeLa CellsHumansImmunity, InnateInterferon-Induced Helicase, IFIH1MiceMice, KnockoutPicornaviridae InfectionsDEAD Box Protein 58DEAD-box RNA HelicasesIFIH1 protein, humanIfnar1 protein, mouseInterferon-Induced Helicase, IFIH1Receptor, Interferon alpha-betaReceptors, ImmunologicRIGI protein, humanRNA, Double-StrandedRNA, MessengerRNA, Small InterferingRNA, ViralTLR3 protein, humanToll-Like Receptor 3

Identifiers

PMID21079690
PMCPMC2973831
OpenAlexW2065445260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.